Atrys Health, S.A. (ATRY) has announced the successful completion of a €72 million capital increase aimed at qualified investors, which also involves the entry of several family offices and international investors.
In order to finance the recent acquisition of the medical oncology company Bienzobas, reported by Legal Dealmaker, the Board of Directors of Atrys agreed to a capital increase with cash contributions and excluding pre-emptive subscription rights at €7.00 per share, of which €0.01 corresponds to the nominal value and €6.99 to the share premium. As a result of the capital increase, Atrys will issue 10,350,000 new shares.
In addition to new Spanish Family Offices, Atrys’ main shareholders, such as Onchena, Mayoral and Caser, as well as the company’s own management team, have also joined Atrys.
For Santiago de Torres, Chairman of Atrys, “this capital increase highlights the attractiveness of our company after its jump to the Main Market and confirms the interest of both national and international investors to join us in our ambitious growth plan. We are very satisfied with the operation and we are especially grateful for the support of the investors who were already with us and who have now increased their participation.”
Atrys will apply for the admission to trading of the new shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges, as well as their inclusion in the Spanish Stock Exchange Interconnection System (SIBE). The shares are expected to be admitted to trading on 15 June and to start trading during the week.
The placement of the new shares has been carried out through an accelerated private placement procedure by Barclays Bank Ireland, Andbank España, Banco de Sabadell, GVC Gaesco Valores and Renta 4 Banco. Mediobanca – Banca di Credito Finanziario S.p.A. acted as financial advisor to the company. Linklaters acted as legal advisor to the underwriters and Gómez-Acebo & Pombo Abogados acted as legal advisor to Atrys.
Linklaters advised the underwriters with a team comprising managing partner Íñigo Berrícano, along with managing associate Álvaro Albors.
Gómez-Acebo & Pombo advised Atrys with a team comprising partner Guillermo Guerra and senior associate Jacobo Palanca.
In-house Legal advice was provided by Atrys Health general counsel Gabriela Camuñas.